92 related articles for article (PubMed ID: 18202031)
21. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
[TBL] [Abstract][Full Text] [Related]
22. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
[TBL] [Abstract][Full Text] [Related]
23. Invasive cervical carcinoma: role of MR imaging in pretreatment work-up--cost minimization and diagnostic efficacy analysis.
Hricak H; Powell CB; Yu KK; Washington E; Subak LL; Stern JL; Cisternas MG; Arenson RL
Radiology; 1996 Feb; 198(2):403-9. PubMed ID: 8596840
[TBL] [Abstract][Full Text] [Related]
24. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
25. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
Ma SK; Wu LY; Sun YC; Li B; Zhang HT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
[TBL] [Abstract][Full Text] [Related]
26. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
27. Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group.
Watanabe Y; Kitagawa R; Aoki D; Takeuchi S; Sagae S; Sakuragi N; Yaegashi N;
Gynecol Oncol; 2009 Dec; 115(3):456-9. PubMed ID: 19765806
[TBL] [Abstract][Full Text] [Related]
28. Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy.
Marana HR; de Andrade JM; Dos Reis FJ; Tiezzi DG; Zola FE; Clagnan WS; Garieri AP
J Surg Oncol; 2009 Nov; 100(6):505-10. PubMed ID: 19653248
[TBL] [Abstract][Full Text] [Related]
29. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
30. Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy.
Magné N; Mancy NC; Chajon E; Duvillard P; Pautier P; Castaigne D; Lhommé C; Morice P; Haie-Meder C
Radiother Oncol; 2009 May; 91(2):197-201. PubMed ID: 18954913
[TBL] [Abstract][Full Text] [Related]
31. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
32. Integration of diagnostic imaging in the clinical management of cervical cancer.
Russell AH
J Natl Cancer Inst Monogr; 1996; (21):35-41. PubMed ID: 9023826
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
34. Patterns of pain and distress during high-dose-rate intracavity brachytherapy for cervical cancer.
Kwekkeboom KL; Dendaas NR; Straub M; Bradley KA
J Support Oncol; 2009; 7(3):108-14. PubMed ID: 19507459
[TBL] [Abstract][Full Text] [Related]
35. Localized in vivo 1H nuclear MR spectroscopy for evaluation of human uterine cervical carcinoma.
Lee JH; Cho KS; Kim YM; Kim ST; Mun CW; Na JH; Mok JE; Lim TH
AJR Am J Roentgenol; 1998 May; 170(5):1279-82. PubMed ID: 9574601
[No Abstract] [Full Text] [Related]
36. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy for patients with localized hormone-refractory prostate cancer: results of the Patterns of Care Study in Japan.
Sasaki T; Nakamura K; Ogawa K; Onishi H; Okamoto A; Koizumi M; Shioyama Y; Mitsumori M; Teshima T;
BJU Int; 2009 Nov; 104(10):1462-6. PubMed ID: 19522869
[TBL] [Abstract][Full Text] [Related]
38. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
39. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
[TBL] [Abstract][Full Text] [Related]
40. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: analysis of surgical and oncological outcome.
Pellegrino A; Vizza E; Fruscio R; Villa A; Corrado G; Villa M; Dell'Anna T; Vitobello D
Eur J Surg Oncol; 2009 Jan; 35(1):98-103. PubMed ID: 18760562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
